Axes Health

Foundation date

01/07/2019

Sector

#Professional Services and Consulting

Subsector

  • design, co-create and implement innovative patient access schemes and HTA strategies for biotech companies

  • multi-stakeholder engagement: patient advocacy, early dialogues with competent authorities, mock negotiations, follow up of pricing and reimbursement procedure and access negotiations (conventions)

  • RWE: coordinating the implementation of sustainable disease registries to support appropriate use, new access schemes, pay for performance arrangements and new type of commercial contracting

Upcoming events

Latest news

  • ANeuroTech receives positive feedback from the FDA for its pivotal Phase IIIb development programme for ANT-01 as an adjunctive anti-depression drug for Major Depressive Disorder

    19 hours ago

  • Confo Therapeutics awarded EUR 1.7M VLAIO grant to expand application of ConfoBody┬« drug discovery and development technology in rare diseases

    Tuesday June 28th 2022

  • MRM Health starts clinical trial with next-generation optimized consortium therapeutic MH002 in Pouchitis

    Tuesday June 28th 2022